Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development Corey E. J.
A comprehensive review of the latest molecular advances in cancer treatmentFeaturing 91 total small molecule kinase/KRAS inhibitors, 80 of which are FDA-approved, Molecules Engineered Against…
Specifikacia Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development Corey E. J.
A comprehensive review of the latest molecular advances in cancer treatmentFeaturing 91 total small molecule kinase/KRAS inhibitors, 80 of which are FDA-approved, Molecules Engineered Against Oncogenic Proteins and Cancer documents the recent scientific advances that have transformed one of medicine's most challenging areas--cancer treatment. Most of these inhibitors specifically block oncogene-induced carcinogenic proteins with results that have dramatically advanced the treatment of cancer. In addition, the structural formulas of more than 100 kinase/KRAS inhibitors in clinical trials are presented.With a very well-known chemist as an author, Molecules Engineered Against Oncogenic Proteins and Cancer includes information on:Each molecule's structure, function of the kinase target and relevance to cancer, the drug discovery process, and